DocSym
β
Searchsearch
Search
(G37.1) Central demyelination of corpus callosum
More details coming soon
549 735 in individuals diagnosis central demyelination of corpus callosum confirmed
10 580 deaths with diagnosis central demyelination of corpus callosum
2% mortality rate associated with the disease central demyelination of corpus callosum
Diagnosis central demyelination of corpus callosum is diagnosed Women are 28.32% more likely than Men
197 036
Men receive the diagnosis central demyelination of corpus callosum
5 942 (3.0 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
352 699
Women receive the diagnosis central demyelination of corpus callosum
4 638 (1.3 %)Died from this diagnosis.
Risk Group for the Disease central demyelination of corpus callosum - Men aged 30-34 and Women aged 35-39
In Men diagnosis is most often set at age 0-84
Less common in men the disease occurs at Age 85-95+Less common in women the disease occurs at Age 90-95+
In Women diagnosis is most often set at age 0-89
Disease Features central demyelination of corpus callosum
Absence or low individual and public risk
Central demyelination of corpus callosum - what does this mean
Central demyelination of the corpus callosum is a condition where the myelin sheath, which is a protective layer around nerve fibers, is damaged, leading to disruption of communication between the two hemispheres of the brain. this can cause a variety of neurological symptoms, such as seizures, cognitive impairment, and motor deficits.
What happens during the disease - central demyelination of corpus callosum
Central demyelination of corpus callosum is a condition in which the myelin sheath, which serves as an insulating layer around the axons of neurons, is damaged or destroyed. this damage can be caused by a variety of factors, including inflammation, infection, or autoimmune disorders. the result is a disruption in the communication between the two hemispheres of the brain, leading to a range of symptoms such as cognitive deficits, impaired motor function, and difficulty with coordination and balance.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Brain Magnetic Resonance Imaging (MRI)
- Neuropsychological Testing
- Cerebrospinal Fluid Analysis
- Evoked Potential Studies (VEP, BAER, SSEP)
- Electroencephalography (EEG)
- Genetic Testing
Treatment and Medical Assistance
Main Goal: To reduce the effects of central demyelination of corpus callosum
- Physical therapy to improve coordination and mobility
- Occupational therapy to increase independence in daily activities
- Speech therapy to improve communication
- Medication to reduce inflammation and improve myelin production
- Counseling to manage stress and emotional issues
- Nutritional therapy to support the body's healing process
- Vitamins and supplements to improve overall health
16 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Central demyelination of corpus callosum - Prevention
The best way to prevent central demyelination of corpus callosum is to maintain a healthy lifestyle by getting regular exercise, eating a balanced diet, avoiding smoking, and managing stress. it is also important to get regular check-ups with a healthcare provider to monitor for any signs or symptoms of the disease.